Construction and prospects of tuberculosis prevention and control service system in China during the new era

doi:10.19983/j.issn.2096-8493.2024025

Abstract

Abstract:

The service system of tuberculosis prevention and control in China has been continuously adjusted and transformed with the changes in epidemic levels and the development of the economy and society. Since 2011, China has gradually implemented the new tuberculosis prevention and control service system. In the new era, how to better improve and perfect the tuberculosis prevention and control service system is a major issue facing tuberculosis prevention and control work. The authors systematically summarized the evolution of China’s tuberculosis prevention and control service system; described the current operation status of the tuberculosis prevention and control service system; analyzed the existing problems and challenges; and put forward the working opinions and suggestions on the construction of the tuberculosis prevention and control service system in the future.

Key words: Tuberculosis, Communicable disease control, Health services research, Clinic practice patterns

CLC Number:

Chen Wei, Sun Huijuan, Zhao Yanlin. Construction and prospects of tuberculosis prevention and control service system in China during the new era[J]. Journal of Tuberculosis and Lung Disease , 2024, 5(2): 95-100. doi: 10.19983/j.issn.2096-8493.2024025

Figures/Tables 4

References 12

[1]	陈松华, 王晓萌, 柴程良, 等. 浅谈“三位一体”结核病防治服务体系建设. 中国防痨杂志, 2016, 38(6):428-431. doi:10.3969/j.issn.1000-6621.2016.06.002.
[2]	国务院办公厅. 国务院办公厅印发《关于推动疾病预防控制事业高质量发展的指导意见》.国办发〔2023〕46号. 2023-12-25.
[3]	姜世闻, 张慧, 王黎霞. 我国结核病防治服务体系的发展与展望. 中国防痨杂志, 2012, 34(9):557-559.
[4]	王黎霞. 中国结核病防治工作现状分析. 中国公共卫生, 2012, 28(4):413-414.
[5]	戴志松. 我国结核病防治服务模式的发展与现状. 预防医学论坛, 2015, 21(12):950-951, 954.
[6]	安立群. 中国结核病控制工作回顾及展望. 职业与健康, 2014, 30(6):842-845.
[7]	李亮, 刘宇红, 马艳, 等. 我国结核病防治服务体系的演变和思考. 中国防痨杂志, 2016, 38(11):904-907. doi:10.3969/j.issn.1000-6621.2016.11.002.
[8]	中共中央办公厅, 国务院办公厅. 中共中央办公厅国务院办公厅印发《关于进一步完善医疗卫生服务体系的意见》. 北京: 中华人民共和国国务院办公厅, 2023(2023-3-23)[2023-12-19]. https://www.gov.cn/zhengce/2023-03/23/content_5748063.htm.
[9]	Tang S, Squire SB. What lessons can de drawn from tuberculosis (TB) Control in China in the 1990s? An analysis from a heath system perspective. Health Policy, 2005, 72(1):93-104. doi:10.1016/j.healthpol.2004.06.009.
[10]	吴周志, 刘军安, 刘晓俊, 等. 我国结核病“三位一体”防治服务模式形成及实践探索. 中国社会医学杂志, 2015, 32(6):419-421.
[11]	国家疾控局国家卫生健康委. 关于印发《医疗机构传染病防控责任清单》的通知.国疾控传防发〔2023〕21号. 2023-10-11.
[12]	王黎霞, 姜世闻. 我国结核病控制策略的发展与展望. 中国防痨杂志, 2014, 36(8)630-633. doi:10.3969/j.issn.1000-6621.2014.08.002.

区划	疾控中心		独立结防所		院所合一^a		慢病院		其他		小计 (家)
区划	数量 (家)	构成比 (%)	数量 (家)	构成比 (%)	数量 (家)	构成比 (%)	数量 (家)	构成比 (%)	数量 (家)	构成比 (%)	小计 (家)
省级	24	75.0	4	12.5	4	12.5	0	0.0	0	0.0	32
地(市)级	258	77.9	24	7.3	40	12.1	9	2.7	0	0.0	331
县(区)级	2463	88.8	182	6.6	24	0.9	72	2.6	33	1.2	2774
合计	2745	87.5	210	6.7	68	2.2	81	2.6	33	1.1	3137

区划	结核病专科医院		综合医院		传染病医院		慢病院		疾控中心		结防所		其他		合计 (家)
区划	数量 (家)	构成比 (%)	数量 (家)	构成比 (%)	数量 (家)	构成比 (%)	数量 (家)	构成比 (%)	数量 (家)	构成比 (%)	数量 (家)	构成比 (%)	数量 (家)	构成比 (%)	合计 (家)
省级	11	33.3	10	30.3	10	30.3	0	0.0	0	0.0	1	3.0	1	3.0	33
地(市)级	33	9.6	179	51.9	92	26.7	6	1.7	1	0.3	22	6.4	12	3.5	345
县(区)级	29	1.2	1967	80.0	20	0.8	74	3.0	154	6.3	169	6.9	46	1.9	2459
合计	73	2.6	2156	76.0	122	4.3	80	2.8	155	5.5	192	6.8	59	2.1	2837

区划	结核病预防控制机构						结核病定点医疗机构							小计
	2020年			2016年			2020				2016
	防治	实验室	小计	防治	实验室	小计	诊疗	影像学检查	实验室	小计	诊疗	影像学检查	实验室
省级	684	151	835	703	157	860	4850	710	624	6184	3951	561	504	5016
地(市)级	2427	434	2861	2547	434	2981	12325	3793	2467	18585	10362	2744	1844	14950
县(区)级	10750	1748	12498	12325	2413	14738	11708	11413	5894	29015	8658	7917	4084	20659
合计	13861	2333	16194	15575	3004	18579	28883	15916	8985	53784	22971	11222	6432	40625

[1]	Lin Ying, Lei Yu, Zhong Miner, Du Yuhua. Construction of a new system of school tuberculosis prevention and control strategy using Delphi evaluation method [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 120-127.
[2]	Zhang Jie, Ding Beichuan, Ren Yixuan, Tian Lili, Yi Junli, Pang Mengdi, Yang Xinyu. Exploring the causes of recurrence and genetic characteristics of tuberculosis strains in Beijing based on genotypic analysis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 128-134.
[3]	Sha Min, Zhu Weidong, Jin Yifan, Lyu Leilei, Chen Cheng. Multidimensional differential diagnosis of pulmonary tuberculosis and pulmonary sarcoidosis accompanied by granulomatous inflammation of pulmonary tissue [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 135-142.
[4]	Li Dan, Zhang Yuhua, Chen Shengyu. Meta-analysis of conventional hypoglycemic and anti-tuberculosis therapy combined with thymosin α1 in the treatment of pulmonary tuberculosis complicated with diabetes [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 148-157.
[5]	Zhang Yajing, Ren Lijun, Wang Mingliang, Jiang Ying, Zhou Lin, Tang Guiqin. Analysis of the epidemic characteristics of pulmonary tuberculosis in Shijingshan District, Beijing from 2012 to 2022 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 158-163.
[6]	Sun Haiyan, Dai Xiaoqi, Song Song, Chen Meng, Xu Honghong, Wang Zhongdong, Zhang Huaqiang. Analysis of the epidemic characteristics of pulmonary tuberculosis in Qingdao from 2008 to 2022 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 164-167.
[7]	National Center of Medical Quality Control for Respiratory Diseases , Tuberculosis Branch of Chinese Medical Association , Tuberculosis Control Branch of Chinese Antituberculosis Association , China⁃Japan Friendship Hospital . Clinical practice guidelines for early detection of pulmonary tuberculosis in general medical facilities [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 1-14.
[8]	hu Wei, Liu Yuhong. Interpretation of WHO global tuberculosis report 2023 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 15-19.
[9]	Ni Nan, Chen Qing, Tang Xianzhen, Zou Liping, Liang Li, Wu Guihui, Mao Li. Analysis of drug resistance status and influencing factors in 203 aged patients with pulmonary tuberculosis combined with type 2 diabetes [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 28-36.
[10]	Yao Xiaowei, Liu Shuren, Jing Yanse, Jia Chenguang. Evaluation of next generation sequencing for the diagnosis of osteoarticular tuberculosis infection [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 37-43.
[11]	Xue Jianhang, Cao hong, Li Lu, Liu Xunrui, Ma Guilin, Zheng Rongrong, Ke Ran. Analysis of treatment outcome and influencing factors of 308 patients with multidrug-resistant pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 44-50.
[12]	Niu Peixuan, A Ertai, Li Yuanyuan, Guan Wenlong, Zheng Tian, Su Dongdong, Du Qingqing, Du Caiyun. Epidemiological characteristics analysis of hospitalized patients with extrapulmonary tuberculosis in Xinjiang Uygur Autonomous Region from 2018 to 2022 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 51-57.
[13]	Yang Chao, Wang Jing, Tang Guilin, Gao Hanqing, Wang Bin. Analysis of patient delay and its influencing factors among elderly pulmonary tuberculosis patients in Tongzhou District of Beijing, 2016—2022 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 58-63.
[14]	Zhang Taifa, Zhou Hua. Epidemiological characteristics of pulmonary tuberculosis in Taicang City from 2017 to 2022 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 64-69.
[15]	Liang Chen, Tang Shenjie, Lin Minggui. Research progress of comprehensive treatment for tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 70-80.